JP

Jignesh Parsotambhai Vadukar

Active Director Director DIN 10720607
DIN 10720607 First appointment Jul 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Jignesh Parsotambhai Vadukar

Data last updated:

Jignesh Parsotambhai Vadukar is a Director at Kjb Healthcare Private Limited (since 2024). The company operates in Paper.

DIN 10720607
Primary Designation Director
Industry Paper
First Appointment 26 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kjb Healthcare Private Limited U21001GJ2024PTC153815
Director26 Jul 20242024Active

Board colleagues of Jignesh Parsotambhai Vadukar

NameDINCompanyDesignation
Brijesh Somabhai Patel10720608Kjb Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kjb Healthcare Private Limited
Premium access

Shareholding and investment profile for Jignesh Parsotambhai Vadukar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jignesh Parsotambhai Vadukar

Jignesh Parsotambhai Vadukar currently holds 1 directorship: Kjb Healthcare Private Limited (Director, since 26 Jul 2024).

Jignesh Parsotambhai Vadukar was first appointed on 26 Jul 2024 as Director at Kjb Healthcare Private Limited.

The current boards of Jignesh Parsotambhai Vadukar's companies include Brijesh Somabhai Patel (Kjb Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available